We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
-3.07%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+473.22%
AUM
$568B
AUM Growth
-$42B
Cap. Flow
-$8.58B
Cap. Flow %
-1.51%
Top 10 Hldgs %
22.78%
Holding
4,890
New
117
Increased
934
Reduced
3,288
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 12.57%
3 Financials 12.04%
4 Consumer Discretionary 10.68%
5 Industrials 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUMU
4451
DELISTED
Qumu Corp.
QUMU
$70K ﹤0.01%
40,030
-457
-1% -$853
BPTH
4452
DELISTED
Bio-Path Holdings Inc
BPTH
$69K ﹤0.01%
887
-18
-2% -$1.31K
ELOX
4453
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$69K ﹤0.01%
3,092
-17
-0.5% -$335
CADL icon
4454
Candel Therapeutics
CADL
$733M
$68K ﹤0.01%
13,455
DOMH icon
4455
Dominari Holdings
DOMH
$57.4M
$68K ﹤0.01%
8,862
CHRN
4456
ChronoScale Holdings
CHRN
$3.2B
$68K ﹤0.01%
1,573
DWTX
4457
Dogwood Therapeutics
DWTX
$55.2M
$68K ﹤0.01%
605
AVAL icon
4458
Grupo Aval
AVAL
$6.27B
$67K ﹤0.01%
14,861
-473
-3% -$2.54K
MRIN
4459
DELISTED
Marin Software
MRIN
$67K ﹤0.01%
3,871
+23
+0.6% +$446
IRD
4460
Opus Genetics
IRD
$306M
$67K ﹤0.01%
20,746
+150
+0.7% +$513
EFTR
4461
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$67K ﹤0.01%
670
+4
+0.6% +$532
LABP
4462
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$67K ﹤0.01%
4,570
-31
-0.7% -$788
CEMI
4463
DELISTED
Chembio diagnostics, Inc.
CEMI
$67K ﹤0.01%
82,143
-1,097
-1% -$1.02K
BTG icon
4464
B2Gold
BTG
$5B
$66K ﹤0.01%
14,315
-289
-2% -$1.16K
CLRB icon
4465
Cellectar Biosciences
CLRB
$20.5M
$66K ﹤0.01%
318
LCI
4466
DELISTED
Lannett Company, Inc.
LCI
$66K ﹤0.01%
21,039
-5,131
-20% -$22.5K
ASAP
4467
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$66K ﹤0.01%
8,914
BLPH
4468
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$66K ﹤0.01%
28,097
-8,313
-23% -$19.8K
CBUS icon
4469
Cibus
CBUS
$147M
$65K ﹤0.01%
1,244
-318
-20% -$23.8K
LSAK icon
4470
Lesaka Technologies
LSAK
$396M
$65K ﹤0.01%
11,021
-1,106
-9% -$5.66K
MBOT icon
4471
Microbot Medical
MBOT
$116M
$65K ﹤0.01%
10,429
-1,449
-12% -$8.49K
XPL icon
4472
Solitario Resources
XPL
$68.3M
$65K ﹤0.01%
77,569
RNTX
4473
Rein Therapeutics
RNTX
$63.1M
$65K ﹤0.01%
6,394
ELYS
4474
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$65K ﹤0.01%
+27,474
New +$73.8K
TYME
4475
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$65K ﹤0.01%
185,608

Similar funds

Northern Trust's Q1 2022 Portfolio in Review

As of Q1 2022, Northern Trust held 4,890 positions worth $568B, down 6.9% from $610B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Northern Trust's Q1 2022 filing shows 117 new, 934 increased, 3,288 reduced and 148 closed positions. Its largest new stake was Constellation Energy: 3,275,992 shares worth $184M. The largest sale was Apple, an estimated $815M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Northern Trust's largest Q1 2022 buy was Constellation Energy: 3,275,992 shares worth $184M.
  • Northern Trust added most to Advanced Micro Devices in Q1 2022, an estimated $534M increase.
  • Northern Trust's biggest Q1 2022 reduction was Apple, cutting an estimated $815M.
  • Northern Trust fully exited Xilinx Inc in Q1 2022, selling an estimated $629M.
  • Northern Trust's ten largest holdings make up 23% of its $568B portfolio in Q1 2022.
  • Northern Trust opened 117 new positions and closed 148 in Q1 2022.
  • Northern Trust's portfolio value fell 6.9% quarter-over-quarter to $568B.

Based on Northern Trust's 13F filing for Q1 2022, filed 13 May 2022.